SI1931363T1 - Zdravljenje vnetnih črevesnih bolezni z uporabo probiotičnih bakterij in fermentiranega žita kot efektorjev zdravljenja - Google Patents
Zdravljenje vnetnih črevesnih bolezni z uporabo probiotičnih bakterij in fermentiranega žita kot efektorjev zdravljenjaInfo
- Publication number
- SI1931363T1 SI1931363T1 SI200632021T SI200632021T SI1931363T1 SI 1931363 T1 SI1931363 T1 SI 1931363T1 SI 200632021 T SI200632021 T SI 200632021T SI 200632021 T SI200632021 T SI 200632021T SI 1931363 T1 SI1931363 T1 SI 1931363T1
- Authority
- SI
- Slovenia
- Prior art keywords
- treatment
- ibd
- effectors
- probiotic bacteria
- fermented cereal
- Prior art date
Links
- 241000894006 Bacteria Species 0.000 title 1
- 235000013339 cereals Nutrition 0.000 title 1
- 239000012636 effector Substances 0.000 title 1
- 239000006041 probiotic Substances 0.000 title 1
- 230000000529 probiotic effect Effects 0.000 title 1
- 235000018291 probiotics Nutrition 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/152—Cereal germ products
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
- A23V2200/3204—Probiotics, living bacteria to be ingested for action in the digestive tract
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Zoology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US72127605P | 2005-09-28 | 2005-09-28 | |
EP05388079A EP1769801A1 (en) | 2005-09-28 | 2005-09-28 | Use of a fermented cereal composition for the treatment of IBD and IBS |
US74471706P | 2006-04-12 | 2006-04-12 | |
DKPA200600529 | 2006-04-12 | ||
EP06776003.3A EP1931363B1 (en) | 2005-09-28 | 2006-09-27 | Treatment of ibd using both probiotic bacteria and fermented cereal as treatment effectors |
PCT/DK2006/000526 WO2007036230A1 (en) | 2005-09-28 | 2006-09-27 | Treatment of ibd and ibs using both probiotic bacteria and fermented cereal as treatment effectors |
Publications (1)
Publication Number | Publication Date |
---|---|
SI1931363T1 true SI1931363T1 (sl) | 2016-02-29 |
Family
ID=43385150
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200632022T SI2277524T1 (sl) | 2005-09-28 | 2006-09-27 | Zdravljenje sindroma razdražljivega črevesja z uporabo probiotičnih bakterij in fermentiranih žit kot efektorjev zdravljenja |
SI200632021T SI1931363T1 (sl) | 2005-09-28 | 2006-09-27 | Zdravljenje vnetnih črevesnih bolezni z uporabo probiotičnih bakterij in fermentiranega žita kot efektorjev zdravljenja |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200632022T SI2277524T1 (sl) | 2005-09-28 | 2006-09-27 | Zdravljenje sindroma razdražljivega črevesja z uporabo probiotičnih bakterij in fermentiranih žit kot efektorjev zdravljenja |
Country Status (10)
Country | Link |
---|---|
US (6) | US20080311097A1 (sl) |
EP (3) | EP3067057B1 (sl) |
JP (4) | JP5363811B2 (sl) |
AU (1) | AU2006296837B2 (sl) |
CA (1) | CA2622951A1 (sl) |
DK (3) | DK3067057T3 (sl) |
ES (2) | ES2561584T3 (sl) |
PL (2) | PL2277524T3 (sl) |
SI (2) | SI2277524T1 (sl) |
WO (1) | WO2007036230A1 (sl) |
Families Citing this family (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2561584T3 (es) * | 2005-09-28 | 2016-02-29 | Nordisk Rebalance A/S | Tratamiento del SII usando como efectores de tratamiento tanto bacterias probióticas como cereales fermentados |
EP2072053B1 (en) * | 2007-12-21 | 2012-11-07 | Compagnie Gervais Danone | Method for decreasing abdominal girth by administering a bifidobacterium bacteria |
FI20085101L (fi) * | 2008-02-05 | 2009-08-06 | Valio Oy | Menetelmä ärtyneen suolen oireyhtymän IBS diagnosoimiseksi |
FI121912B (fi) * | 2008-02-05 | 2011-06-15 | Valio Oy | Probioottien uusi käyttö |
EP2300977A4 (en) * | 2008-05-15 | 2014-04-30 | Youdocs Llc | METHOD AND SYSTEMS FOR IMPROVING HUMAN HEALTH USING TARGETED PROBIOTICS |
NL1036661C2 (en) * | 2009-03-04 | 2010-09-07 | Serrix B V | Anti-fungal compounds & compositions. |
WO2011047153A1 (en) * | 2009-10-15 | 2011-04-21 | President And Fellows Of Harvard College | Methods for modulating autoimmunity |
CA2784723C (en) * | 2009-12-22 | 2021-01-12 | Probi Ab | Non-fermented compositions comprising a cereal based fraction and a probiotic and uses thereof |
WO2011082218A1 (en) * | 2009-12-31 | 2011-07-07 | Ira Milton Trachtman | Compositions and method for treatment and prophylaxis of inflammatory bowel disease |
WO2011148219A1 (en) | 2010-05-28 | 2011-12-01 | Compagnie Gervais Danone | Probiotic strains for use in improving the enteric nervous system |
WO2011148220A1 (en) | 2010-05-28 | 2011-12-01 | Compagnie Gervais Danone | Probiotic strains for use in improving transepithelial resistance |
TWI392498B (zh) * | 2010-07-19 | 2013-04-11 | Synbio Tech Inc | 戊糖乳桿菌lps16及其在抑制幽門螺旋桿菌之用途 |
PL2651423T3 (pl) | 2010-12-17 | 2016-05-31 | Gervais Danone Sa | Szczepy lactococcus lactis do stosowania w poprawie stanu trawienia |
CN103648511B (zh) * | 2011-06-08 | 2018-12-07 | 诺沃奇梅兹有限公司 | 喷雾干燥的乳杆菌属菌株/细胞及其对抗幽门螺杆菌的用途 |
US9579353B2 (en) * | 2011-06-10 | 2017-02-28 | Prothera, Inc. | Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes |
JP5928774B2 (ja) * | 2011-11-01 | 2016-06-01 | 株式会社大阪ソーダ | β−1,3−グルカンを含む過敏性腸症候群の下痢抑制剤、腹痛改善剤、及び大腸における痛覚過敏改善剤 |
PL2780023T3 (pl) * | 2011-11-16 | 2018-06-29 | Multigerm Uk Entpr Ltd | Leczenie IBS za pomocą probiotyków |
WO2013099883A1 (ja) * | 2011-12-28 | 2013-07-04 | 株式会社山田養蜂場本社 | IgA産生促進作用を有する新規乳酸菌及びその用途 |
JP6267129B2 (ja) * | 2011-12-29 | 2018-01-24 | ヒルズ・ペット・ニュートリシャン・インコーポレーテッド | 消化管フローラを改良する組成物および方法 |
DE102012002592A1 (de) | 2012-02-13 | 2013-08-14 | Dr. Kurt Wolff Gmbh & Co. Kg | Verwendung eines Mittels zur Stimulation der Gen-Expression antimikrobieller Peptide (AMP) |
MX2015006491A (es) | 2012-11-23 | 2015-12-03 | Seres Health Inc | Composiciones bacterianas sinergicas y metodos de produccion y uso de las mismas. |
US8906668B2 (en) | 2012-11-23 | 2014-12-09 | Seres Health, Inc. | Synergistic bacterial compositions and methods of production and use thereof |
US11179427B2 (en) | 2013-01-21 | 2021-11-23 | Eth Zurich | Baby food composition comprising viable propionic acid-producing bacteria |
DE102013100891A1 (de) * | 2013-01-29 | 2014-07-31 | Erdinger Weissbräu Franz Brombach e.K. | Verfahren zur Herstellung eines Sauergutes, einer Maische oder Würze, eines Getränks, eines Konzentrats sowie die damit hergestellten Erzeugnisse und Verwendung von Milchsäurebakterien, eines Sauerguts, einer Maische, einer Würze oder eines Konzentrats |
DE102013008335A1 (de) * | 2013-01-29 | 2014-07-31 | Erdinger Weissbräu Franz Brombach e.K. | Verfahren zur Herstellung eines Nahrungsmittels sowie das damit hergestellte Nahrungsmittel und Verwendung von Milchsäurebakterien, eines Sauerguts, einer Maische, einer Würze, eines Getränks oder eines Konzentrats |
RU2664479C2 (ru) | 2013-02-04 | 2018-08-17 | Серес Терапеутикс, Инк. | Композиции и способы |
US10973861B2 (en) | 2013-02-04 | 2021-04-13 | Seres Therapeutics, Inc. | Compositions and methods |
WO2014145958A2 (en) | 2013-03-15 | 2014-09-18 | Seres Health, Inc. | Network-based microbial compositions and methods |
CN104208294B (zh) * | 2013-09-29 | 2018-01-16 | 河南后羿实业集团有限公司 | 一种用于治疗仔猪黄白痢的中药组合物及其制备方法 |
AU2014352643A1 (en) | 2013-11-25 | 2016-06-30 | Seres Therapeutics, Inc. | Synergistic bacterial compositions and methods of production and use thereof |
US9956282B2 (en) | 2013-12-16 | 2018-05-01 | Seres Therapeutics, Inc. | Bacterial compositions and methods of use thereof for treatment of immune system disorders |
CN104435354A (zh) * | 2014-11-21 | 2015-03-25 | 王正琦 | 治疗儿童消化不良的口服液 |
CN104524006A (zh) * | 2014-12-26 | 2015-04-22 | 邓小健 | 健胃消食片及其生产方法 |
GB201501938D0 (en) * | 2015-02-05 | 2015-03-25 | Multigerm Uk Entpr Ltd | Probiotic preparation |
CN104623145A (zh) * | 2015-02-12 | 2015-05-20 | 苏州市天灵中药饮片有限公司 | 一种用于治疗细菌性痢疾的中药提取物及其制备方法 |
WO2016183535A1 (en) | 2015-05-14 | 2016-11-17 | University Of Puerto Rico | Methods for restoring microbiota of newborns |
RU2738803C2 (ru) * | 2015-08-25 | 2020-12-17 | Иммьюнбиотек Медикал Свиден Аб | Композиция и способ лечения и профилактики кишечной инфекции и воспаления |
EP3626081B1 (en) * | 2015-09-10 | 2022-02-09 | Université catholique de Louvain | Pasteurized akkermansia for promoting weight loss |
JP6759337B2 (ja) * | 2015-10-26 | 2020-09-23 | シージェー チェイルジェダン コーポレーション | 酵素生産能が優秀である伝統発酵食品由来の新たな菌株及びこれを用いた穀物発酵酵素食品の製造方法 |
US11564667B2 (en) | 2015-12-28 | 2023-01-31 | New York University | Device and method of restoring microbiota of newborns |
MX2018009539A (es) | 2016-02-04 | 2019-02-11 | Univ Gent | Uso de comunidades microbianas para la salud humana y animal. |
JP6329206B2 (ja) * | 2016-06-30 | 2018-05-23 | ヒルズ・ペット・ニュートリシャン・インコーポレーテッド | 消化管フローラを改良する組成物および方法 |
WO2018195067A1 (en) | 2017-04-17 | 2018-10-25 | The University Of Chicago | Polymer materials for delivery of short-chain fatty acids to the intestine for applications in human health and treatment of disease |
US11273198B2 (en) * | 2017-05-04 | 2022-03-15 | Second Genome, Inc. | Proteins for the treatment of epithelial barrier function disorders |
US11174293B2 (en) | 2017-06-02 | 2021-11-16 | Second Genome, Inc. | Proteins for the treatment of epithelial barrier function disorders |
GB201709763D0 (en) * | 2017-06-19 | 2017-08-02 | Probi Ab | Biological materials and methods |
AU2018318132A1 (en) | 2017-08-14 | 2020-02-27 | Seres Therapeutics, Inc. | Compositions and methods for treating cholestatic disease |
US10485253B2 (en) | 2017-08-21 | 2019-11-26 | Mustapha Benmoussa | Method of microalgal biomass processing for high-value chemicals production, the resulting composition of butyrogenic algal slowly fermenting dietary fiber, and a way to improve colon health using a slowly fermenting butyrogenic algal dietary fiber |
EP3453395B1 (en) * | 2017-09-08 | 2023-10-18 | Deutsches Rheuma-Forschungszentrum Berlin | Anaeroplasmatales for use in the treatment or prevention of an inflammatory disorder of the digestive system |
JP7215026B2 (ja) * | 2018-09-13 | 2023-01-31 | ライオン株式会社 | 口腔用組成物 |
CN110624060A (zh) * | 2019-07-25 | 2019-12-31 | 秦剑 | 一种治疗幼儿腹泻的中药制剂及其制备方法 |
CN110452860A (zh) * | 2019-09-24 | 2019-11-15 | 厦门大学 | 一种唾液链球菌及其在治疗炎症性肠病药物中的应用 |
TWI777475B (zh) * | 2021-03-30 | 2022-09-11 | 豐華生物科技股份有限公司 | 使用乳酸菌菌株組合來治療第1型糖尿病 |
WO2023135274A1 (en) | 2022-01-14 | 2023-07-20 | Nordic Rebalance A/S | Compositions for treatment of a fatty liver or fibrotic liver disease |
WO2024017920A1 (en) | 2022-07-18 | 2024-01-25 | Nordic Rebalance A/S | Composition comprising fermented cereal gruel |
WO2024123266A2 (en) * | 2022-12-07 | 2024-06-13 | Yaşar Üni̇versi̇tesi̇ | Fermented breakfast cereal base preparation |
CN115969957B (zh) * | 2022-12-21 | 2023-07-11 | 浙江佰穗莱生命健康科技有限公司 | 一种炎性肠病复合益生菌制剂及其制备方法 |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4839281A (en) | 1985-04-17 | 1989-06-13 | New England Medical Center Hospitals, Inc. | Lactobacillus strains and methods of selection |
AU624067B2 (en) | 1986-12-12 | 1992-06-04 | Biorem C.C. | Preparation suitable for use in the treatment of enteric disorders |
DK686187D0 (da) | 1987-12-23 | 1987-12-23 | Hansens Chr Bio Syst | Veterinaert praeparat |
SE463796B (sv) | 1988-03-09 | 1991-01-28 | Carl Erik Albertsson | Foerfarande foer framstaellning av en naeringskomposition och daervid framstaelld naeringskomposition |
DE8910369U1 (de) | 1989-08-30 | 1990-06-28 | Siemens AG, 1000 Berlin und 8000 München | Stellantrieb |
WO1991005851A1 (en) | 1989-10-10 | 1991-05-02 | Tartusky Gosudarstvenny Universitet | Bacterium strain lactobacillus casei subsp. casei 37 for production of a bacterial biological preparation |
WO1991005850A1 (en) | 1989-10-10 | 1991-05-02 | Tartusky Gosudarstvenny Universitet | Bacterium strain lactobacillus plantarum 38 for production of a bacterial biological preparation |
FI88856C (fi) | 1990-05-18 | 1997-07-01 | Alko Yhtioet Oy | Foerfarande foer framstaellning av ett fermenterat, huvudsakligen pao havrekli baserat, levande mikroorganismer innehaollande livsmedel |
SE469875C (sv) | 1991-07-25 | 1997-04-14 | Probi Ab | Stam av tarmkoloniserande Lactobacillus samt komposition för profylax eller behandling av infektioner i magtarmkanalen |
SE9501056D0 (sv) * | 1995-03-23 | 1995-03-23 | Probi Ab | Epithelial adherent lactobacilli |
SE9501719D0 (sv) | 1995-05-09 | 1995-05-09 | Probi Ab | Pharmaceutical composition |
EP0922395A4 (en) | 1997-04-01 | 1999-12-22 | Nichimo Kk | PRODUCT COMPRISING A HEALTH-FRIENDLY INGREDIENT AND PROCESS FOR PRODUCING THE SAME |
SE511025C2 (sv) | 1997-10-03 | 1999-07-26 | Probi Ab | Foderprodukt för häst omfattande Lactobacillus plantarum JI:1 samt Lactobacillus plantarum JI:1 och användning därav |
SE523771C2 (sv) * | 1999-05-21 | 2004-05-18 | Probi Ab | Sportdryck innehållande mikronäringsämnen i kombination med levande laktobaciller |
EP1276488B1 (en) | 2000-03-24 | 2006-12-20 | Societe Des Produits Nestle S.A. | Use of lactic acid bacterium for the prevention of peritonitis |
SE0003045D0 (sv) | 2000-08-29 | 2000-08-29 | Probi Ab | New method |
DE10042825A1 (de) | 2000-08-30 | 2002-03-28 | New Food Ag | Wurst- und Pökelware |
SE0004124D0 (sv) * | 2000-11-10 | 2000-11-10 | Probi Ab | New use |
GB0027761D0 (en) | 2000-11-14 | 2000-12-27 | Nestle Sa | Nutritional composition for an immune condition |
EP1243273A1 (en) | 2001-03-22 | 2002-09-25 | Societe Des Produits Nestle S.A. | Composition comprising a prebiotic for decreasing infammatory process and abnormal activation of non-specific immune parameters |
WO2002086136A1 (en) | 2001-04-25 | 2002-10-31 | N.V. Nutricia | Process for the manufacture of a fermented health-promoting product |
DE10219684A1 (de) * | 2001-05-04 | 2002-11-14 | Unternehmensberatung Reichenau | Ernährungsprodukt, Pflegeprodukt und Herstellungsverfahren |
DE10258129A1 (de) | 2002-12-02 | 2004-06-17 | Andrea Reichenauer-Feil | Lebensmittelzubereitung |
SE526711C2 (sv) | 2003-01-31 | 2005-10-25 | Probi Ab | Nya stammar av Bifidobacterium med förmåga att överleva i magtarmkanalen och producera glutamin in vivo, samt kompositioner och användningar därav |
SE527555C2 (sv) | 2003-04-04 | 2006-04-11 | Probi Ab | Anti-inflammatorisk komposition innehållande tannasproducerande Lactobacillusstammar |
ES2561584T3 (es) * | 2005-09-28 | 2016-02-29 | Nordisk Rebalance A/S | Tratamiento del SII usando como efectores de tratamiento tanto bacterias probióticas como cereales fermentados |
-
2006
- 2006-09-27 ES ES06776003.3T patent/ES2561584T3/es active Active
- 2006-09-27 ES ES10182284.9T patent/ES2561629T3/es active Active
- 2006-09-27 WO PCT/DK2006/000526 patent/WO2007036230A1/en active Application Filing
- 2006-09-27 DK DK15194713.2T patent/DK3067057T3/da active
- 2006-09-27 EP EP15194713.2A patent/EP3067057B1/en active Active
- 2006-09-27 AU AU2006296837A patent/AU2006296837B2/en not_active Ceased
- 2006-09-27 CA CA002622951A patent/CA2622951A1/en not_active Abandoned
- 2006-09-27 EP EP10182284.9A patent/EP2277524B1/en active Active
- 2006-09-27 PL PL10182284T patent/PL2277524T3/pl unknown
- 2006-09-27 JP JP2008532598A patent/JP5363811B2/ja not_active Expired - Fee Related
- 2006-09-27 EP EP06776003.3A patent/EP1931363B1/en active Active
- 2006-09-27 DK DK06776003.3T patent/DK1931363T3/en active
- 2006-09-27 PL PL06776003T patent/PL1931363T3/pl unknown
- 2006-09-27 SI SI200632022T patent/SI2277524T1/sl unknown
- 2006-09-27 DK DK10182284.9T patent/DK2277524T3/en active
- 2006-09-27 SI SI200632021T patent/SI1931363T1/sl unknown
- 2006-09-27 US US12/066,246 patent/US20080311097A1/en not_active Abandoned
-
2012
- 2012-07-03 US US13/540,827 patent/US8846029B2/en active Active
-
2013
- 2013-03-14 US US13/826,208 patent/US9205114B2/en active Active
- 2013-03-14 US US13/826,076 patent/US8900570B2/en active Active
- 2013-04-10 JP JP2013082426A patent/JP5706461B2/ja not_active Expired - Fee Related
- 2013-04-10 JP JP2013082427A patent/JP5802235B2/ja not_active Expired - Fee Related
-
2015
- 2015-06-04 JP JP2015113693A patent/JP6150353B2/ja active Active
- 2015-08-25 US US14/834,639 patent/US20150359836A1/en not_active Abandoned
-
2017
- 2017-02-15 US US15/433,982 patent/US10286026B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL1931363T3 (pl) | Leczenie IBD z zastosowaniem zarówno bakterii probiotycznych, jak i sfermentowanych zbóż jako efektorów leczenia | |
EP1928995A4 (en) | PREPARATIONS BASED ON VIABLE MICRO-ORGANISMS AND METHODS OF MAKING AND USING SAME | |
EP1859022A4 (en) | NEW SAFETY TOLERANT LACTOBACILLUS SAKEI PROBIO-65 WITH THE CAPACITY TO SUPPORT GROWTH-BASED MICRO-ORGANISMS AND ANTI-ALLERGIC EFFECTS | |
EP1812023B8 (en) | Lactic acid bacteria as probiotic strains and compositions containing same | |
HK1145406A1 (en) | Novel bacteria and methods of use thereof | |
EP2066785A4 (en) | BACTERIAL CULTURES AND COMPOSITIONS WITH BACTERIAL CULTURES | |
IL178686A (en) | Preparations of bacterial strain of lactic acid and their uses | |
WO2008117266A3 (en) | Probiotic bifidobacterium strains | |
EP2046352A4 (en) | FERMENTED MILK PRODUCT AND ITS USE | |
HK1173747A1 (en) | Induction and stabilization of enzymatic activity in microorganisms | |
ZA200710983B (en) | Bacterial cellulose-containing formulations and method of producing effective bacterial cellulose-containing formulations | |
EP1900285A4 (en) | FERMENTED FOOD CONTAINING BIFIDOBACTERIUM BACTERIUM AND METHOD FOR PRODUCING THE SAME | |
EP1948812A4 (en) | ENZYM AND METHODS FOR TREATING A BIOMASS | |
WO2005060707A3 (en) | Methods of use of probiotic lactobacilli for companion animals | |
EP1880614A4 (en) | NEW MICRO-ORGANISM AND PROCESS FOR PREPARING FRESH COFFEE BEANS USING THIS | |
ZA200900235B (en) | Prevention and treatment of otitis media with non-pathogenic bacterial strains | |
EP1848798A4 (en) | NEW MICROBIAL ENZYMES AND THEIR USE | |
AP2007004168A0 (en) | Bacteriocins and novel bacterial strains | |
EP1915443A4 (en) | IMMOBILIZED ENZYMES AND USE METHOD THEREFOR | |
IL180459A0 (en) | Treatment of bacterial infections | |
GB0720997D0 (en) | Methods of altering gene expression and methods of treatment utilizing same | |
EP1994117A4 (en) | NEUTRALIZATION OF BACTERIA SPORES | |
EP1999248A4 (en) | DEVICES AND METHODS FOR ISOLATION AND CULTURE OF MICROORGANISMS | |
EP1885848A4 (en) | MICROBIAL CONVERSION OF SACCHARIC ACIDS AND MEANS USED IN THIS CONVERSION | |
GB0518921D0 (en) | Enzymatic composition and method of textile treatment |